NCT04309357View on ClinicalTrials.gov

Thrombolysis Outcome in Ischemic Stroke

CompletedOBSERVATIONAL
Enrollment

214

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

April 30, 2020

Study Completion Date

May 30, 2020

Conditions
Stroke, AcuteThrombolytic TherapyAlteplaseMortality
Interventions
DRUG

Alteplase

Alteplase in dose 0.9 mg/kg in acute ischemic patient with indications of thrombolytic therapy

Trial Locations (1)

Unknown

Bu Ali Sina hospital , Mazandarn University of Medical Science, Sari

All Listed Sponsors
lead

Mazandaran University of Medical Sciences

OTHER

NCT04309357 - Thrombolysis Outcome in Ischemic Stroke | Biotech Hunter | Biotech Hunter